BELGA-POX
BELGA-POX
Authorised
- Fowlpox virus, strain IP72, Live
Product identification
Medicine name:
BELGA-POX
Active substance:
- Fowlpox virus, strain IP72, Live
Target species:
-
Pigeon
Route of administration:
-
Topical
Product details
Active substance and strength:
-
Fowlpox virus, strain IP72, Live3.50log 10 50% embryo infective dose0.04millilitre(s)
Pharmaceutical form:
-
Lyophilisate for suspension for injection
Withdrawal period by route of administration:
-
Topical
- Pigeon
-
All relevant tissues0day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01ED01
Legal status of supply:
This information is not available for this product.
Authorisation status:
-
Valid
Authorised in:
-
Romania
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone) - Directive No 2001/82/EC
Marketing authorisation holder:
- Pasteur Filiala Filipesti S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Pasteur Filiala Filipesti S.A.
Responsible authority:
- Institute For Control Of Biological Products And Veterinary Medicines
Authorisation number:
- 190166
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it in another language below.
Romanian (PDF)
Published on: 25/05/2022
How useful was this page?: